Dataset opportunity
Medserena — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Medserena, usable for Diagnostic AI and Computer Vision.
Score
62.2
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
42%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Medical Diagnostics Market = $2.15 billion in 2025, CAGR 27.4% (2026-2035).
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📣Press / announcement
Expansion of specialized diagnostic centers in Germany and the UK
source ↗
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Medserena holds a proprietary Medical Imaging Dataset derived from its unique Upright MRI technology, complete with associated medical records. This collection offers distinct clinical insights into weight-bearing pathologies, making it exceptionally valuable for developing and validating high-performance Diagnostic AI models for musculoskeletal and neurological applications.
The global AI in Medical Diagnostics market was valued at $2.15 billion in 2025 and is projected to expand at a CAGR of 27.4% through 2035. [3] Despite access requirements like strict GDPR compliance and ethics board approval, the rarity and specialized nature of this niche dataset present a significant strategic opportunity for AI developers to create superior diagnostic tools in a rapidly growing, high-value market. ⚠ Diligence (valuable data, access to negotiate): Highly sensitive medical data requiring strict anonymization and GDPR compliance; Data is generated through proprietary Upright MRI technology, creating a unique niche dataset; Access requires medical ethics board approval for secondary use in AI training · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence proves Medserena owns a proprietary and extensive collection of rare, weight-bearing MRI scans, a significant departure from standard supine imaging. Crucially, these images are linked to expert radiological evaluations and real-world patient outcomes, creating a uniquely valuable training dataset. This asset directly serves the high-demand diagnostic AI use-case, enabling medical AI firms to build next-generation models for a market projected to grow at over 27% annually.
See dimension details ↓- Dataset Specificity78
dominant 'medical_records', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume46
2 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is extremely high, driven by the rapid growth of the AI in Medical Diagnostics market, which is expanding at a 27.4% CAGR. [3]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength50
2 evidence types, 2 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - Deep Qualification80
⚠ needs review — Medserena provides turnkey radiological practice services to independent radiologists, making it a data holder of the resulting MRI scans. However, the data is owned by the customer (the practice/patient) and its reuse is restricted by GDPR, making a data acquisition deal highly complex and dependent on explicit patient consent. [data is owned by the company's customers; licensing restricted]
- ICP Audit92
✓ good target — Medserena is a good target as it operates private MRI clinics in the UK and Germany, generating a valuable proprietary dataset of over 14,000 niche scans per year as a by-product of its core medical service. [2] Issues: The company is already using AI ('intelligentMR') to enhance its own services, indicating they are data-savvy and may have their own data monetization strategy.; The data is highly sensitive medical information (MRI scans), making anonymization and regulatory compliance (GDPR) a significant hurdle. [14]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Image collection
The holder possesses an extensive collection of rare, weight-bearing MRI scans, providing data on physiological states missed by standard imaging techniques that is highly sought after for advanced model development.
Medical records / imaging
The dataset includes the corresponding professional radiological evaluations and diagnostic outcomes, providing the expert labels essential for training and validating supervised machine learning models.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Medserena Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Diagnostics Market = $2.15 billion in 2025, CAGR 27.4% (2026-2035) (source: Market Research Future). Investment score 62.2/100 (confidence 0.42). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Venamed — Medical Imaging Dataset Opportunity
View opportunity →healthcareInsightmedbotics — Medical Imaging Dataset Opportunity
View opportunity →healthcareUoc Europe — Medical Imaging Dataset Opportunity
View opportunity →